全球牙菌斑修復及去除设备市场

到 2030 年，全球牙菌斑修復和去除设备市场规模将达到 30 亿美元

全球牙菌斑修復和去除设备市场规模预计在2024年达到20亿美元，预计在2024-2030年的分析期内将以7.3%的复合年增长率增长，到2030年将达到30亿美元。动脉粥状动脉粥状硬化斑块切除术设备是本报告分析的细分市场之一，预计其复合年增长率将达到8.8%，到分析期结束时将达到14亿美元。血栓切除设备细分市场在分析期间的复合年增长率预计为5.0%。

美国市场规模估计为 5.329 亿美元，中国市场预计复合年增长率为 11.6%

预计2024年，美国牙菌斑修復去除设备市场规模将达到5.329亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到6.364亿美元，在2024-2030年的分析期间内，复合年增长率为11.6%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.5%和7.1%。在欧洲，预计德国市场的复合年增长率为4.8%。

全球牙菌斑修復和去除设备市场—主要趋势和驱动因素摘要

由于心血管疾病 (CVD) 盛行率的不断上升、微创技术的进步以及导管式斑块清除技术的偏好，牙菌斑修復和清除设备市场正在经历显着增长。随着动脉粥状硬化和周边动脉疾病(PAD) 的日益普遍，对有效安全的斑块清除技术的需求日益增长，尤其是在老龄化人口以及糖尿病、肥胖症和高血压患者群体中。

影响市场发展的关键趋势之一是微创斑块清除技术的日益普及。与传统外科手术相比，该技术能够缩短患者恢復时间、降低手术风险并改善长期疗效。动脉粥状硬化斑块切除术斑块切除设备、雷射斑块清除系统和机械血栓切除工具正变得越来越先进，能够精准定位并更安全地清除冠状动脉和周边动脉中的斑块。这些技术创新尤其有利于复杂钙化病变、慢性完全闭塞性病变 (CTO) 和高风险心血管疾病患者。

市场成长的另一个关键驱动力是将先进的影像和导航技术融入斑块修復设备。血管内超音波(IVUS)、光同调断层扫瞄(OCT) 和即时血管造影术辅助导引系统正在增强斑块表征、病灶评估和手术准确性。这些影像技术使心臟科医师和血管外科医师能够确定斑块成分、优化器械选择并彻底修復病变，从而降低再狭窄和併发症的血管再阻塞。

此外，生物可吸收支架和药物涂层球囊技术的兴起正在补充斑块清除策略，从而实现持续的血管通畅和改善的术后结果。随着监管部门的核准不断扩大和临床试验证明的长期疗效，全球医院和门诊手术中心 (ASC) 对下一代斑块清除和矫正解决方案的需求预计将增长。

科技创新如何改变斑块改造设备？

斑块修復产业正经历快速的技术进步，重点是仪器精度、降低手术风险和改善患者预后。新一代动脉动脉粥状硬化斑块切除术设备、射频雷射系统和机械抽吸血栓切除设备正在提高复杂高风险患者斑块清除的有效性。

该领域最显着的创新之一是轨道式和旋转式动脉粥状动脉粥状硬化斑块切除术术设备的开发。这些以导管为基础的系统采用差异化切割技术，选择性地去除钙化斑块，同时保留健康动脉组织的完整性。钻石涂层钻头和旋转能量的使用可以精确矫正动脉斑块，改善血流并减少重复干预的需要。

另一项突破是基于雷射的斑块清除系统，该系统利用高能量雷射脉衝汽化动脉粥样硬化斑块。这些设备精度高，可减少对血管壁的损伤，并提高支架内血管再阻塞治疗的效果。尤其是准分子雷射导管，已被证明在复杂的冠状动脉和周边血管介入治疗中非常有效，斑块施加机械力即可控制性地斑块。

除了机械和雷射方法外，超音波增强和衝击波碎石技术已成为治疗钙化斑块的有前景的选择。血管内碎石术 (IVL) 可释放声压碎裂硬化斑块，从而以最小的血管创伤将斑块去除。该技术在复杂的介入心臟病学中正被广泛采用，尤其是在糖尿病患者以及常规治疗难以治癒的严重钙化病变。

此外，针对斑块的生物工程奈米颗粒和药物释放型斑块修饰装置正在开发中，旨在实现靶向斑块溶解和血管稳定。这些基于奈米技术的解决方案有望降低手术风险，最大程度地减少发炎反应，并提高斑块清除手术的持久性，是未来研究和临床应用的重要重点。

临床应用和最终用户偏好如何影响市场需求？

周边动脉疾病(PAD)、颈动脉疾病和冠状动脉疾病 (CAD) 的盛行率不断上升，显着影响了牙菌斑修復和清除设备的需求。随着越来越多的患者寻求非手术干预治疗动脉阻塞，医院、心血管诊所和门诊手术中心 (ASC) 正在采用先进的斑块清除技术来满足临床需求。

週边血管介入是发展最快的领域之一，其中动脉粥状硬化斑块动脉粥状硬化斑块切除术和雷射斑块清除装置被广泛用于治疗股动脉和膝下动脉闭塞。週边动脉疾病 (PAD) 影响全球数百万人，如果不及时治疗，可能导致危急性肢体缺血(CLI) 和截肢。导管斑块清除装置的出现显着提高了肢体存活率和长期血管通畅性，使其成为现代血管外科的重要组成部分。

冠状动脉介入治疗领域也越来越多地采用斑块修復技术，尤其是在球囊血管成形术或置入术无效的钙化冠状动脉病变患者。旋动脉粥状硬化斑块切除术、血管内碎石术和雷射斑块清除术目前是高经皮经皮冠状动脉介入治疗 (PCI) 的首选方案，可改善病灶准备和支架置入术的疗效。

另一个新兴应用是颈动脉疾病的治疗，斑块清除装置有助于预防中风和脑血管事件。混合斑块修復技术，将动脉粥状硬化切除术术与栓塞保护过滤器和药物涂层球囊相结合，改善了颈重组的疗效，并降低了远端栓塞和血管再阻塞的风险。

此外，门诊心血管手术在心臟外科中心 (ASC) 和诊室实验室 (OBL) 的应用日益增多，也推动了对紧凑易用的斑块清除设备的需求。一次性导管式动脉粥状动脉粥状硬化斑块切除术系统和经济高效的雷射平台可实现当天出院并减少住院时间，使斑块修復治疗对更广泛的患者群体更易于获得且更经济实惠。

哪些因素推动了牙菌斑改造和去除设备市场的成长？

牙菌斑修復和去除设备市场的成长受到多种因素的推动，包括微创心血管手术的进步、週边和冠状动脉疾病的盛行率增加、即时成像和人工智慧主导的分析的整合以及门诊心血管护理环境的扩展。

全球动脉粥状硬化和心血管疾病 (CVD) 负担日益加重，是市场的主要驱动力。人口老化、久坐不动的生活方式以及代谢紊乱（例如糖尿病和肥胖症）的持续上升，推动了对有效的导管斑块清除解决方案的需求。医生们正在寻求更安全、更快速、更持久的干预措施，精准动脉粥状动脉粥状硬化斑块切除术、雷射消熔和震波碎石术已成为现代心血管医学的重要工具。

另一个关键驱动因素是人工智慧辅助影像处理和手术导航系统的快速发展。人工智慧平台增强了术前规划、术中指导和术后监测，使介入医生能够检测复杂斑块、优化设备选择并提高手术安全性。人工智慧与血管内超音波 (IVUS)、光学相干断层扫描 (OCT) 和血管造影术的结合显着降低了併发症发生率、再血管再阻塞风险和手术失败率，进一步促进了市场应用。

门诊循环系统护理的扩展和门诊手术中心 (ASC) 的兴起也推动了市场的成长。随着医疗保健系统转向经济高效的当日手术，对便携式、易于使用的斑块清除技术的需求日益增长。各公司正在推出一次性斑块动脉粥状硬化斑块切除术设备、微型雷射系统和一次性碎石导管，以促进从医院到门诊的医疗服务转型。

此外，下一代斑块修復设备的监管核准和临床试验的成功正在加速其商业化进程。主要企业正在投资生物可吸收支架、基于奈米技术的斑块标靶治疗以及混合动脉粥状硬化斑块切除术切除术-支架系统的研发，以确保长期血管通畅性并改善心血管健康状况。

随着精准心血管介入的需求不断增长，随着技术进步、人工智慧主导的诊断和微创治疗的创新塑造动脉粥状硬化管理和血管医学的未来，牙菌斑修改和去除设备市场预计将大幅扩张。

部分

产品（动脉粥状硬化斑块切除术装置、血栓除去装置、慢性阻塞装置、栓塞保护装置）；应用（冠状动脉疾病、周边动脉疾病）；最终用途（医院、门诊手术中心、其他）

受访公司范例

• Abbott Laboratories
• AngioDynamics, Inc.
• Asahi Intecc Co., Ltd.
• Avinger, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company（BD）
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cardiovascular Systems, Inc.
• Edwards Lifesciences Corporation
• Johnson & Johnson
• Medtronic plc
• Merit Medical Systems, Inc.
• MicroPort Scientific Corporation
• Penumbra, Inc.
• Philips Healthcare
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation

人工智慧集成

我们正在利用有效的专家内容和人工智慧工具来改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Plaque Modification and Removal Devices Market to Reach US$3.0 Billion by 2030

The global market for Plaque Modification and Removal Devices estimated at US$2.0 Billion in the year 2024, is expected to reach US$3.0 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Atherectomy Devices, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Thrombectomy Devices segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$532.9 Million While China is Forecast to Grow at 11.6% CAGR

The Plaque Modification and Removal Devices market in the U.S. is estimated at US$532.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$636.4 Million by the year 2030 trailing a CAGR of 11.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Plaque Modification and Removal Devices Market - Key Trends & Drivers Summarized

The plaque modification and removal devices market is witnessing significant growth, driven by rising cases of cardiovascular diseases (CVDs), advancements in minimally invasive procedures, and increasing preference for catheter-based plaque removal techniques. As atherosclerosis and peripheral artery disease (PAD) become more prevalent, the need for effective and safe plaque removal technologies is growing, particularly among aging populations and individuals with diabetes, obesity, and hypertension.

One of the major trends shaping the market is the increasing adoption of minimally invasive plaque removal techniques, which offer faster recovery times, reduced procedural risks, and improved long-term outcomes compared to traditional surgical methods. Atherectomy devices, laser-based plaque removal systems, and mechanical thrombectomy tools are becoming more sophisticated, enabling precise targeting and safer plaque removal in coronary and peripheral arteries. These innovations are particularly beneficial for patients with complex calcified lesions, chronic total occlusions (CTOs), and high-risk cardiovascular conditions.

Another key driver of market growth is the integration of advanced imaging and navigation technologies in plaque modification devices. Intravascular ultrasound (IVUS), optical coherence tomography (OCT), and real-time angiography-assisted guidance systems are enhancing plaque characterization, lesion assessment, and procedural accuracy. These imaging techniques allow cardiologists and vascular surgeons to determine plaque composition, optimize device selection, and ensure complete lesion modification, reducing the risk of restenosis and complications.

Additionally, the rise of bioresorbable stents and drug-coated balloon technologies is complementing plaque removal strategies, providing sustained vessel patency and improved post-procedural outcomes. With regulatory approvals expanding and clinical trials demonstrating positive long-term efficacy, the demand for next-generation plaque removal and modification solutions is expected to rise in both hospital settings and ambulatory surgical centers (ASCs) worldwide.

How Are Technological Innovations Transforming Plaque Modification Devices?

The plaque modification industry is undergoing rapid technological advancements, with a strong focus on device precision, reduced procedural risks, and improved patient outcomes. Next-generation atherectomy devices, high-frequency laser systems, and mechanical aspiration thrombectomy tools are enhancing the effectiveness of plaque removal in complex and high-risk patients.

One of the most notable innovations in the field is the development of orbital and rotational atherectomy devices. These catheter-based systems use differential cutting technology to selectively remove calcified plaque while preserving the integrity of healthy arterial tissue. The use of diamond-coated burrs and rotational energy allows for precise modification of arterial plaques, improving blood flow and reducing the need for repeat interventions.

Another groundbreaking advancement is laser-based plaque removal systems, which utilize high-energy laser pulses to vaporize atherosclerotic plaques. These devices offer exceptional precision, reduced trauma to vessel walls, and enhanced efficacy in treating in-stent restenosis. Excimer laser catheters, in particular, are proving to be highly effective in complex coronary and peripheral interventions, allowing controlled ablation of calcified and fibrotic plaques without mechanical force.

In addition to mechanical and laser-based approaches, ultrasound-enhanced and shockwave lithotripsy technologies are emerging as promising alternatives for calcified plaque modification. Intravascular lithotripsy (IVL) delivers acoustic pressure waves to fracture hardened plaques, facilitating their removal with minimal vessel trauma. This technique is gaining widespread adoption in complex cardiovascular interventions, particularly in patients with diabetes and heavily calcified lesions that are resistant to traditional treatments.

Moreover, bioengineered plaque-targeting nanoparticles and drug-eluting plaque modification devices are in development to provide targeted plaque dissolution and vessel stabilization. These nanotechnology-based solutions are expected to reduce procedural risks, minimize inflammatory responses, and enhance the durability of plaque removal procedures, making them a key focus for future research and clinical applications.

How Are Clinical Applications and End-User Preferences Shaping Market Demand?

The demand for plaque modification and removal devices is heavily influenced by the increasing prevalence of peripheral artery disease (PAD), carotid artery disease, and coronary artery disease (CAD). As more patients seek non-surgical interventions for arterial blockages, hospitals, specialty cardiovascular clinics, and ambulatory surgical centers (ASCs) are adopting advanced plaque removal technologies to meet clinical demands.

One of the fastest-growing segments is peripheral vascular interventions, where atherectomy and laser plaque removal devices are widely used to treat femoropopliteal and infrapopliteal arterial blockages. PAD affects millions of people worldwide, leading to critical limb ischemia (CLI) and potential limb amputation if left untreated. The availability of catheter-based plaque removal tools has significantly improved limb salvage rates and long-term vessel patency, making these devices essential in modern vascular surgery.

The coronary intervention sector is also seeing increased adoption of plaque modification technologies, particularly in patients with calcified coronary lesions that are resistant to balloon angioplasty and stenting. Rotational atherectomy, intravascular lithotripsy, and laser-assisted plaque removal are now preferred options for high-risk percutaneous coronary interventions (PCIs), offering better lesion preparation and stent expansion outcomes.

Another emerging application is in the treatment of carotid artery disease, where plaque removal devices are helping to prevent stroke and cerebrovascular events. Hybrid plaque modification techniques, combining atherectomy with embolic protection filters and drug-coated balloons, are enhancing carotid revascularization outcomes, reducing the risk of distal embolization and restenosis.

Moreover, the rising adoption of outpatient cardiovascular procedures in ASCs and office-based labs (OBLs) is driving demand for compact, user-friendly plaque removal devices. Single-use, disposable catheter-based atherectomy systems and cost-effective laser platforms are enabling same-day discharge and reduced hospital stays, making plaque modification treatments more accessible and affordable for a broader patient population.

What Factors Are Driving the Growth of the Plaque Modification and Removal Devices Market?

The growth in the plaque modification and removal devices market is driven by several factors, including advancements in minimally invasive cardiovascular procedures, increasing prevalence of peripheral and coronary artery diseases, the integration of real-time imaging and AI-driven analytics, and the expansion of outpatient cardiovascular care settings.

The rising global burden of atherosclerosis and cardiovascular disease (CVD) is a primary market driver. As aging populations, sedentary lifestyles, and metabolic disorders (such as diabetes and obesity) continue to rise, the demand for effective, catheter-based plaque removal solutions is increasing. Physicians are seeking safer, faster, and more durable interventions, making high-precision atherectomy, laser ablation, and shockwave lithotripsy devices critical tools in modern cardiovascular medicine.

Another key factor is the rapid development of AI-assisted imaging and procedural navigation systems. AI-powered platforms are enhancing pre-procedural planning, intraoperative guidance, and post-procedural monitoring, allowing interventionalists to detect complex plaques, optimize device selection, and improve procedural safety. The integration of AI with IVUS, OCT, and angiography is significantly reducing complication rates, restenosis risks, and procedural failures, further driving market adoption.

The expansion of outpatient cardiovascular care and the rise of ambulatory surgical centers (ASCs) are also fueling market growth. With healthcare systems shifting toward cost-effective, same-day procedures, the demand for portable, easy-to-use plaque removal technologies is increasing. Companies are introducing disposable atherectomy devices, compact laser systems, and single-use lithotripsy catheters to support the transition from hospital-based interventions to office-based treatments.

Moreover, regulatory approvals and clinical trial success in next-generation plaque modification devices are accelerating commercialization. Leading companies are investing in research and development (R&D) for bioresorbable scaffolds, nanotechnology-based plaque-targeting therapies, and hybrid atherectomy-stent systems, ensuring long-term vessel patency and improved cardiovascular health outcomes.

As the demand for precision-based cardiovascular interventions continues to grow, the plaque modification and removal devices market is expected to expand significantly, with technological advancements, AI-driven diagnostics, and minimally invasive treatment innovations shaping the future of atherosclerosis management and vascular health care.

SCOPE OF STUDY:

The report analyzes the Plaque Modification and Removal Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices, Embolic Protection Devices); Application (Coronary Artery Disease, Peripheral Artery Disease); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• AngioDynamics, Inc.
• Asahi Intecc Co., Ltd.
• Avinger, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company (BD)
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cardiovascular Systems, Inc.
• Edwards Lifesciences Corporation
• Johnson & Johnson
• Medtronic plc
• Merit Medical Systems, Inc.
• MicroPort Scientific Corporation
• Penumbra, Inc.
• Philips Healthcare
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Plaque Modification and Removal Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Peripheral and Coronary Artery Disease Drives Demand for Plaque Modification Devices
  • Increased Use of Endovascular Procedures Spurs Adoption of Atherectomy and Thrombectomy Technologies
  • Technological Innovations in Rotational, Orbital, and Laser-Based Atherectomy Enhance Precision and Efficacy
  • Shift Toward Minimally Invasive Cardiovascular Interventions Strengthens Demand for Plaque Removal Systems
  • Aging Population and Rising Diabetic Patient Base Expand the Target Pool for PAD and CAD Therapies
  • Surge in Complex Lesions and Calcified Arteries Spurs Development of Specialty Modification Devices
  • Regulatory Approvals and Favorable Reimbursement in Developed Markets Accelerate Procedure Volumes
  • Integration of Imaging-Guided and AI-Driven Device Navigation Improves Safety and Clinical Outcomes
  • Hospital Infrastructure Modernization and Hybrid Cath Lab Expansion Support Device Adoption
  • Increasing Adoption of Drug-Coated Balloons and Stents Encourages Pre-Treatment with Debulking Devices
  • Strategic Collaborations Between Medtech Firms and Cardiovascular Specialists Accelerate Innovation
  • Growth of Ambulatory Surgery Centers (ASCs) Enhances Use of Portable and Cost-Efficient Devices
  • Surge in Clinical Trials and Real-World Evidence Supporting Efficacy of Plaque Removal Boosts Physician Confidence
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Plaque Modification and Removal Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Plaque Modification and Removal Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Plaque Modification and Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Atherectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Atherectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Atherectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Thrombectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Chronic Occlusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Chronic Occlusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Chronic Occlusion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Embolic Protection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Embolic Protection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Embolic Protection Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Coronary Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Coronary Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Coronary Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Peripheral Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Peripheral Artery Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Peripheral Artery Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• JAPAN
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• CHINA
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• EUROPE
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Plaque Modification and Removal Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Plaque Modification and Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• FRANCE
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• GERMANY
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Plaque Modification and Removal Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• INDIA
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Plaque Modification and Removal Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Plaque Modification and Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Plaque Modification and Removal Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Plaque Modification and Removal Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030
• AFRICA
  • Plaque Modification and Removal Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Plaque Modification and Removal Devices by Product - Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Plaque Modification and Removal Devices by Product - Percentage Breakdown of Value Sales for Atherectomy Devices, Thrombectomy Devices, Chronic Occlusion Devices and Embolic Protection Devices for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Plaque Modification and Removal Devices by Application - Coronary Artery Disease and Peripheral Artery Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Plaque Modification and Removal Devices by Application - Percentage Breakdown of Value Sales for Coronary Artery Disease and Peripheral Artery Disease for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Plaque Modification and Removal Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Plaque Modification and Removal Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Others for the Years 2015, 2025 & 2030

IV. COMPETITION